Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.32 |
| ▸ | REN | P00797 | 6/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2789916 | 0.93 | REN (0.32) | RENCYP3A4ALDH1A1TSHRKMT2A | |
| SCHEMBL7898919 | 0.92 | USP30 (0.32) | USP30KLK5AAK1SCN9A | |
| SCHEMBL7890024 | 0.89 | KLK5 (0.36) | KLK5RENCYP3A4ALDH1A1TSHR | |
| SCHEMBL2813840 | 0.89 | KLK5 (0.36) | KLK5RENCYP3A4ALDH1A1TSHR | |
| SCHEMBL7905913 | 0.89 | CACNA1B (0.35) | KLK5RENCYP3A4ALDH1A1TSHR | |
| SCHEMBL2813838 | 0.89 | KLK5 (0.36) | KLK5RENCYP3A4ALDH1A1TSHR | |
| SCHEMBL7902463 | 0.88 | USP30 (0.33) | USP30KLK5AAK1SCN9A | |
| SCHEMBL7902090 | 0.88 | USP30 (0.32) | USP30KLK5RENCYP3A4AAK1 | |
| SCHEMBL7898296 | 0.87 | CNR2 (0.33) | USP30KLK5RENCYP3A4AAK1 | |
| SCHEMBL7897503 | 0.85 | SCN9A (0.32) | KLK5RENCYP3A4ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010111634-A2 | RENIN INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-30 | — | — | WO | disclosed |